CEREBELLAR CYST

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting CEREBELLAR CYST:

# Drug Count
0 ADO-TRASTUZUMAB EMTANSINE 3
1 FAM-TRASTUZUMAB DERUXTECAN-NXKI 2
2 ANASTROZOLE 1
3 ANASTROZOLE TABLETS 1
4 CARBOPLATIN 1
5 DABRAFENIB 1
6 DENOSUMAB 1
7 DOCETAXEL 1
8 DOCETAXEL ANHYDROUS 1
9 GOSERELIN 1
See all common drugs associated with CEREBELLAR CYST

CEREBELLAR CYST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SELUMETINIB 1 0.0006
1 ADO-TRASTUZUMAB EMTANSINE 3 0.0004
2 FAM-TRASTUZUMAB DERUXTECAN-NXKI 2 0.0002
3 GOSERELIN 1 0.0001
4 DABRAFENIB 1 0.0000
5 ANASTROZOLE TABLETS 1 0.0000
6 TRAMETINIB 1 0.0000
7 PERTUZUMAB 1 0.0000
8 ANASTROZOLE 1 0.0000
9 DOCETAXEL 1 0.0000
See all drugs enriched for association with CEREBELLAR CYST

CEREBELLAR CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 HER2/neu Receptor Antagonist [EPC] 1 0.0000
1 Aromatase Inhibitor [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 1 0.0000
3 RANK Ligand Inhibitor [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with CEREBELLAR CYST